Denub 60mg Injection

Product Description

Denub 60mg Injection contains Denosumab, a monoclonal antibody used primarily in the treatment of bone-related conditions. Denosumab works by inhibiting a protein involved in bone resorption, making it useful in conditions where bone density needs to be preserved or enhanced.

To be sure the prescription is safe for you, let your doctor know about all the medications you take. Before using, women who are pregnant or nursing should speak with their doctor.

Brand Name: Denub

Composition: Denosumab

Mechanism of Action:

Denosumab is a RANK ligand (RANKL) inhibitor that binds to and inactivates RANKL, a protein essential for the formation, function, and survival of osteoclasts (cells that break down bone). By inhibiting RANKL, Denosumab reduces bone resorption and increases bone density, thereby lowering the risk of fractures.

Uses:

Osteoporosis

Bone Loss

Giant Cell Tumor of Bone

Hypercalcemia of Malignancy

Dosage and Administration:

60 mg subcutaneously once every 6 months for osteoporosis; other conditions may have different dosing schedules. Administered as a subcutaneous injection in the upper arm, upper thigh, or abdomen.

Side Effects:

Back pain

Musculoskeletal pain

High cholesterol

Urinary tract infections

Rash

Hypocalcemia (low blood calcium levels)

Osteonecrosis of the jaw

Femur fractures

Hair loss

Nerve Pain